FDA approves gene-editing treatment for sickle cell disease

Sickle cell disease affects approximately 100,000 people in the U.S., predominantly people of color.

FDA approves gene-editing treatment for sickle cell disease
Sickle cell disease affects approximately 100,000 people in the U.S., predominantly people of color.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow